Antivirals

COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying...


The FDA ( US Food and Drug Administration ) has approved a supplemental New Drug Application ( sNDA) for...


The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated...


Data has demonstrated that choosing a different combination of direct-acting antiviral ( DAA ) treatment for hepatitis C can eradicate...


Herpes zoster is common and vaccine preventable. Stroke risk may be increased following zoster, but evidence is sparse and could...


Results from studies in chronic hepatitis C patients with human immunodeficiency virus type 1 ( HIV-1 ) co-infection ( TURQUOISE-I...


Hepatitis C virus ( HCV ) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with...


The approval of two hepatitis C virus ( HCV ) protease inhibitors by the FDA ( Food and Drug Administration...


Improved understanding of HCV replication has allowed for the development of new therapeutic agents that target enzymes directly. HCV is...


Sovaldi ( Sofosbuvir ) is the first-in-class medicine that provides the first interferon-free treatment option in patients chronic hepatitis C.Hepatitis...